Home › Sezary Syndrome › Texas › Houston
Sezary Syndrome clinical trials in Houston, TX
4 studies for Sezary Syndrome are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
RecruitingObservational study
- M D Anderson Cancer Center, Houston
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- The University of Texas - MD Anderson Cancer Center, Houston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- MD Anderson Cancer Center (Data Collection Only), Houston
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Sezary Syndrome trials in other cities
- Baldwin Park, CA7 studies
- Mountain View, CA5 studies
- Atlanta, GA4 studies
- New York City, NY4 studies
- Boston, MA4 studies
- Pittsburgh, PA3 studies
- Tampa, FL3 studies
- Philadelphia, PA3 studies
- St. Louis, MO3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)123 studies
- Metastatic Cancer104 studies
- Colorectal Cancer101 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.